- Home
- AAP vs PCVX Comparison
AAP vs PCVX Comparison
Compare AAP & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAP
- PCVX
- Stock Information
- Founded
- AAP 1929
- PCVX 2013
- Country
- AAP United States
- PCVX United States
- Employees
- AAP N/A
- PCVX N/A
- Industry
- AAP Auto & Home Supply Stores
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- AAP Consumer Discretionary
- PCVX Health Care
- Exchange
- AAP Nasdaq
- PCVX Nasdaq
- Market Cap
- AAP 3.3B
- PCVX 6.0B
- IPO Year
- AAP N/A
- PCVX 2020
- Fundamental
- Price
- AAP $49.75
- PCVX $49.03
- Analyst Decision
- AAP Hold
- PCVX Strong Buy
- Analyst Count
- AAP 20
- PCVX 7
- Target Price
- AAP $52.28
- PCVX $101.67
- AVG Volume (30 Days)
- AAP 1.9M
- PCVX 1.4M
- Earning Date
- AAP 10-30-2025
- PCVX 11-04-2025
- Dividend Yield
- AAP 2.00%
- PCVX N/A
- EPS Growth
- AAP N/A
- PCVX N/A
- EPS
- AAP N/A
- PCVX N/A
- Revenue
- AAP $8,624,327,000.00
- PCVX N/A
- Revenue This Year
- AAP N/A
- PCVX N/A
- Revenue Next Year
- AAP $0.89
- PCVX N/A
- P/E Ratio
- AAP N/A
- PCVX N/A
- Revenue Growth
- AAP N/A
- PCVX N/A
- 52 Week Low
- AAP $28.89
- PCVX $27.66
- 52 Week High
- AAP $70.00
- PCVX $98.17
- Technical
- Relative Strength Index (RSI)
- AAP 43.30
- PCVX 69.14
- Support Level
- AAP $46.11
- PCVX $40.14
- Resistance Level
- AAP $52.17
- PCVX $45.90
- Average True Range (ATR)
- AAP 3.15
- PCVX 2.30
- MACD
- AAP 0.22
- PCVX 0.26
- Stochastic Oscillator
- AAP 27.04
- PCVX 91.15
About AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.